Press Releases
Philips debuts fully integrated suite of enhanced patient monitoring solutions in U.S. market
Royal Philips , a global leader in health technology announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system...
Industry Reports
Debt-burdened CHS Sells TN Hospital to Cash-strapped Rennova
Rennova was delisted by Nasdaq for excessive stock splitting, and closed with a market cap of $112,793, and shares valued at less than $1...
Industry Reports
Allergan Reports Solid Finish to 2017 with 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3 Billion
Allergan plc reported its fourth quarter and full-year 2017 continuing operations performance.
Total fourth quarter net revenues were $4.33 billion, a 12.0 percent increase from...
Industry Reports
Cardinal Health Announces Closing of Cardinal Health China Distribution Business Divestiture to Shanghai Pharma
Cardinal Health announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma"). The sale...
Industry Reports
Stryker reports 2017 results and 2018 outlook
Stryker Corporation reported 2017 operating results for the fourth quarter and full year and 2018 outlook:
Fourth Quarter Highlights
Net sales grew 10.0% to $3.5...
Research Insight
Long-term protection against HIV : Gene therapy using CAR T cells
A UCLA-led research team has created blood-forming stem cells that can carry a gene that allows the body to produce cells that can detect...
Press Releases
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): A multicentre, open-label, single-arm, phase 2 trial
Regimens based on ibrutinib alone and lenalidomide and rituximab in combination show high activity in patients with relapsed or refractory mantle cell lymphoma. We...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read